Molecular pharming biomimetics

A.Edible vaccines against HIV (humans), with double action against CTV (plants)-Gene therapy

B. Cell-microbiome therapy against breast cancer. We do have preliminary data in the lab.

—

Democratising a multi-versatile & personalized molecular pharming platform via a hybrid of an organic unique tree^microbiome; genetic bottleneck, banker bioreactor pipeline compiled with a stochastic RNA bioenergetics modality: Low-cost quantum eco-evo biomimetic prototypes for scale-up capacity on a TAM of 50% CAGR. TRL:5

agriculture,food, health, space and energy sector.